Mao, S., Zhang, J., Guo, Y., Zhang, Z., Wu, Y., Zhang, W., . . . Yao, X. (2019). Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: A case report. Drug Des Devel Ther.
استشهاد بنمط شيكاغوMao, Shiyu, et al. "Hyperprogression After Anti-programmed Cell Death Ligand-1 Therapy in a Patient With Recurrent Metastatic Urothelial Bladder Carcinoma Following First-line Cisplatin-based Chemotherapy: A Case Report." Drug Des Devel Ther 2019.
MLA استشهادMao, Shiyu, et al. "Hyperprogression After Anti-programmed Cell Death Ligand-1 Therapy in a Patient With Recurrent Metastatic Urothelial Bladder Carcinoma Following First-line Cisplatin-based Chemotherapy: A Case Report." Drug Des Devel Ther 2019.